scholarly article | Q13442814 |
P2093 | author name string | Shuang Wu | |
Xiaofei Li | |||
Yongxin Chen | |||
Jinhong Zhu | |||
Lianqing Lou | |||
Weiwei Ye | |||
Xingfei Tao | |||
P2860 | cites work | WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis | Q24650922 |
Regulation of pancreatic function by connective tissue growth factor (CTGF, CCN2) | Q27012580 | ||
Smad-dependent and Smad-independent pathways in TGF-beta family signalling | Q28208250 | ||
CCN3 (NOV) is a negative regulator of CCN2 (CTGF) and a novel endogenous inhibitor of the fibrotic pathway in an in vitro model of renal disease | Q28568759 | ||
Functional contribution of elevated circulating and hepatic non-classical CD14CD16 monocytes to inflammation and human liver fibrosis | Q33604746 | ||
Pathogenesis of liver fibrosis: role of oxidative stress | Q34025940 | ||
WISP-1 binds to decorin and biglycan | Q34094910 | ||
Narrative review: fibrotic diseases: cellular and molecular mechanisms and novel therapies | Q34096270 | ||
Activation of the connective tissue growth factor (CTGF)-transforming growth factor β 1 (TGF-β 1) axis in hepatitis C virus-expressing hepatocytes | Q34441588 | ||
The value of alpha-SMA in the evaluation of hepatic fibrosis severity in hepatitis B infection and cirrhosis development: a histopathological and immunohistochemical study. | Q34444717 | ||
The CCN family: a new stimulus package | Q35194555 | ||
Connective tissue growth factor (CTGF, CCN2) gene regulation: a potent clinical bio-marker of fibroproliferative disease? | Q37373460 | ||
Molecular pathogenesis of liver fibrosis | Q37600646 | ||
Causes of and prevention strategies for hepatocellular carcinoma. | Q38030772 | ||
CCN3/NOV small interfering RNA enhances fibrogenic gene expression in primary hepatic stellate cells and cirrhotic fat storing cell line CFSC. | Q39508427 | ||
Anti-fibrotic effect of CCN3 accompanied by altered gene expression profile of the CCN family | Q41516168 | ||
Heme oxygenase-1 prevents liver fibrosis in rats by regulating the expression of PPARγ and NF-κB. | Q41953790 | ||
Ozone preconditioning and exposure to ketamine attenuates hepatic inflammation in septic rats | Q42076844 | ||
Wnt-induced secreted protein-1 is a prohypertrophic and profibrotic growth factor | Q42515433 | ||
Conditional tetracycline-regulated expression of TGF-β1 in liver of transgenic mice leads to reversible intermediary fibrosis | Q44419371 | ||
Hemizygous deletion of CTGF/CCN2 does not suffice to prevent fibrosis of the severely injured kidney | Q58423188 | ||
Chemokines in Liver Inflammation and Fibrosis | Q84603395 | ||
P433 | issue | 3 | |
P304 | page(s) | 647-653 | |
P577 | publication date | 2015-06-01 | |
P1433 | published in | Archives of Medical Science | Q15753010 |
P1476 | title | Blockade of CCN4 attenuates CCl4-induced liver fibrosis | |
P478 | volume | 11 |